MedPath

A prospective multicenter randomized controlled trial for the effect of high-dose corticosteroid on refractory Mycoplasma Pneumoniae pneumonia in childre

Not Applicable
Conditions
Mycoplasma Pneumoniae pneumonia
Registration Number
JPRN-UMIN000031674
Lead Sponsor
agoya University Graduate School of Medicine, Department of Pediatrics / Developmental Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Patients 1.who need intubation by respiratory failure 2.who do not receive enough antibiotics therapy(at least by 2 groups of antibiotics ;Macrolid, Newquinolone or tetracycline) 3.who receive steroid therapy except for refractory Mycoplasma Pneumoniae pneumonia (such as asthma) who diagnosed as other diseases, such as HPS or Kawasaki Disease. 4.with Congenital heart diseases, metabolic disorder, neurologic dis order, bronchopulmonary disorder, or immune deficiency 5.who have allery of steroid 6.who is negative in immune-serological verification

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath